2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{2-[2-(trifluoromethyl)-1H-benzimidazol-1-yl]ethyl}acetamide
Chemical Structure Depiction of
2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{2-[2-(trifluoromethyl)-1H-benzimidazol-1-yl]ethyl}acetamide
2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{2-[2-(trifluoromethyl)-1H-benzimidazol-1-yl]ethyl}acetamide
Compound characteristics
| Compound ID: | Y042-2641 |
| Compound Name: | 2-(2,5-dioxo-2,3,4,5-tetrahydro-1H-1,4-benzodiazepin-3-yl)-N-{2-[2-(trifluoromethyl)-1H-benzimidazol-1-yl]ethyl}acetamide |
| Molecular Weight: | 445.4 |
| Molecular Formula: | C21 H18 F3 N5 O3 |
| Smiles: | C(C1C(Nc2ccccc2C(N1)=O)=O)C(NCCn1c2ccccc2nc1C(F)(F)F)=O |
| Stereo: | RACEMIC MIXTURE |
| logP: | 2.2386 |
| logD: | 2.2262 |
| logSw: | -3.1344 |
| Hydrogen bond acceptors count: | 7 |
| Hydrogen bond donors count: | 3 |
| Polar surface area: | 85.442 |
| InChI Key: | QAGXGXDCLMVURA-HNNXBMFYSA-N |